United States v. Morsell

30 M.J. 808, 1990 CMR LEXIS 501, 1990 WL 59598
CourtU S Air Force Court of Military Review
DecidedApril 26, 1990
DocketACM 28015
StatusPublished

This text of 30 M.J. 808 (United States v. Morsell) is published on Counsel Stack Legal Research, covering U S Air Force Court of Military Review primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Morsell, 30 M.J. 808, 1990 CMR LEXIS 501, 1990 WL 59598 (usafctmilrev 1990).

Opinion

DECISION

KASTL, Senior Judge:

It is elementary catechism in military law that this Court will approve only so much of the findings and sentence as we find correct in fact and law under Article 66(c), UCMJ, 10 U.S.C. § 866(c). A trial forum’s findings must be accorded great weight because of its advantage in seeing and hearing the witnesses. Nonetheless, we too must be convinced of an appellant’s guilt beyond a reasonable doubt. Here, we are not. We will dismiss the Charge and specification and set aside the sentence.

Despite her pleas of not guilty, Sergeant Morsell was convicted of wrongful use of cocaine (a violation of Article 112a, UCMJ, 10 U.S.C. § 912a) before a general court-martial consisting of members. Her approved sentence is a bad conduct discharge, confinement for two months, and reduction to airman basic.

A lynchpin in the prosecution case at trial was the appellant’s positive urinalysis [809]*809test after a random sweep in April 1988. That test showed a concentration of the cocaine metabolite benzoylecgonine of 183 nanograms per milliliter. The defense countered with evidence of Sergeant Morsell’s good military character, her testimony that she had never used cocaine, and— most significantly — evidence that the urinalysis sample attributed to her may not have been hers. This last contention was supported, the defense claimed, by the results of a defense-requested blood grouping “secretor” test.

In preparation for this court-martial, the defense concluded that such a secretor test was indispensable. It was their theory that a forensic comparison between a Lewis secretor test and the urine specimen allegedly given by Sergeant Morsell in April 1988 would exonerate her. They requested the convening authority to approve employment of a private toxicology laboratory to perform secretor testing. The Government countered with an alternative plan — taking secretor samples at the Malcolm Grow Medical Center at Andrews Air Force Base, Maryland and testing elsewhere within the military forensic system. Specimens of blood, urine, and saliva were collected at Malcolm Grow in September 1988.

Before going to the hospital to provide these specimens, Sergeant Morsell received two letters from the assistant trial counsel. They were intended to expedite collection of the specimens. The assistant trial counsel then telephoned the officer in charge of the laboratory to advise him that Sergeant Morsell would be arriving to submit specimens for secretor studies. He passed on guidance as to the procedure which should be followed.

We believe an inadvertent error occurred in either the speaking of this guidance, its hearing, or “passing the word” among the laboratory staff. These technicians concluded that there was no requirement for the usual strict observation procedures. Malcolm Grow medical personnel did not directly observe the collection of the samples, positively identify the specimen donor, or ensure all positive controls over the specimens. The specimens were shipped to the crime lab at Fort Gillem, Georgia, where forensic secretor tests were performed by an Army chemist with expertise in the area. His task was to compare the “Malcolm Grow sample” to the sample which had been identified earlier as belonging to the appellant and containing the cocaine metabolite.

That chemist testified at trial for the defense. He related that, after comparing results of the two tests, in his judgment, either: (a) the April 1988 positive urine sample supposedly from Sergeant Morsell did not come from her body; or (b) that urine sample had so degraded that accurate results or comparisons between it and the September 1988 secretor test were impossible. The Army chemist also testified that deterioration of the April 1988 urine sample was unlikely.

At trial, the prosecution offered another theory — the urine test was fine but the secretion test was suspect because of flaws in its chain of custody. It was at this juncture that the defense learned for the first time that direct observation, required by Air Force Regulation 160-23, Drug Abuse Testing Program, para. 7 (31 July 1986), had not occurred as to the secretor test. The defense team claimed surprise by the Government’s attack on the chain of custody. The defense was unsuccessful in winning a delay or temporary excusal of one of the defense counsel to conduct further discovery on the issue.

The members found the appellant guilty as charged.

As to the unfortunate breaches in the chain of custody and observation procedures, we find no evidence whatsoever of intentional misconduct by the prosecution team. In this, we are in full accord with the limited post-trial hearing findings of the military judge, commendably appointed by the convening authority under R.C.M. 1102(b)(2) to take evidence on the issue. In well-articulated findings, he found the prosecution had made (at worst) an honest mistake, in good faith. We concur.

During the post-trial hearing, the defense argued strongly that the Govern[810]*810ment’s misadventure amounted to an error of constitutional proportions.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
30 M.J. 808, 1990 CMR LEXIS 501, 1990 WL 59598, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-morsell-usafctmilrev-1990.